11/20/24 20:00 | 11/19/24 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | S | -614 | 22.41 | 0 | -27 | 0 | 6,906 | D | | | | | | | | | | | | | | |
11/19/24 18:15 | 11/16/24 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 56 | 1 | 6,933 | D | | | | | | | | | | | | | | |
8/20/24 18:31 | 8/16/24 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 56 | 1 | 6,906 | D | | | | | | | | | | | | | | |
8/20/24 18:31 | 8/19/24 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | S.d | -676 | 24.69 | 0 | -27 | 0 | 6,906 | D | | | | | | | | | | | | | | |
5/17/24 16:11 | 5/16/24 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 61 | 1 | 6,906 | D | | | | | | | | | | | | | | |
2/21/24 16:03 | 2/16/24 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 102 | 2 | 6,876 | D | | | | | | | | | | | | | | |
11/20/23 16:00 | 11/16/23 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 102 | 2 | 6,822 | D | | | | | | | | | | | | | | |
11/20/23 16:00 | 11/17/23 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S.d | -1,500 | 29.10 | 0 | -52 | -1 | 6,822 | D | | | | | | | | | | | | | | |
8/18/23 16:00 | 8/16/23 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 102 | 2 | 6,822 | D | | | | | | | | | | | | | | |
8/18/23 16:00 | 8/17/23 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S.d | -1,474 | 28.59 | 0 | -52 | -1 | 6,822 | D | | | | | | | | | | | | | | |
5/18/23 16:07 | 5/16/23 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 102 | 2 | 6,822 | D | | | | | | | | | | | | | | |
5/18/23 16:07 | 5/17/23 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S.d | -722 | 14.01 | 0 | -52 | -1 | 6,822 | D | | | | | | | | | | | | | | |
5/5/23 16:03 | 5/3/23 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | -1,702 | 14.18 | 0 | -120 | -2 | 6,822 | I | | | | | | | | | | | | | | |
4/7/23 16:39 | 4/5/23 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | -1,856 | 15.46 | 0 | -120 | -2 | 6,942 | I | | | | | | | | | | | | | | |
3/3/23 20:01 | 3/3/23 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | -1,315 | 10.96 | 0 | -120 | -2 | 7,062 | I | | | | | | | | | | | | | | |
2/21/23 20:12 | 2/16/23 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 69 | 1 | 7,182 | D | | | | | | | | | | | | | | |
2/21/23 20:12 | 2/17/23 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S.d | -569 | 12.70 | 0 | -45 | -1 | 7,182 | D | | | | | | | | | | | | | | |
2/6/23 19:26 | 2/3/23 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | -1,321 | 11.01 | 0 | -120 | -2 | 7,182 | I | | | | | | | | | | | | | | |
1/6/23 20:35 | 1/5/23 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | -921 | 7.67 | 0 | -120 | -2 | 7,302 | I | | | | | | | | | | | | | | |
12/21/22 19:58 | 12/21/22 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | 0 | 0.00 | 0 | -200 | -3 | 7,422 | I | | | | | | | | | | | | | | |
11/18/22 18:42 | 11/16/22 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 69 | 1 | 7,622 | D | | | | | | | | | | | | | | |
11/18/22 18:42 | 11/17/22 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S.d | -326 | 9.40 | 0 | -35 | 0 | 7,622 | D | | | | | | | | | | | | | | |
8/18/22 18:39 | 8/16/22 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 69 | 1 | 7,622 | D | | | | | | | | | | | | | | |
5/18/22 16:06 | 5/16/22 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 69 | 1 | 7,581 | D | | | | | | | | | | | | | | |
2/18/22 16:35 | 2/16/22 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 8 | 0 | 7,536 | D | | | | | | | | | | | | | | |
11/18/21 16:05 | 11/16/21 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 8 | 0 | 7,531 | D | | | | | | | | | | | | | | |
8/18/21 16:06 | 8/16/21 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 8 | 0 | 7,527 | D | | | | | | | | | | | | | | |
5/18/21 18:29 | 5/16/21 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 8 | 0 | 7,524 | D | | | | | | | | | | | | | | |
2/18/21 19:45 | 2/16/21 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 5 | 0 | 7,520 | D | | | | | | | | | | | | | | |
11/18/20 19:51 | 11/16/20 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 5 | 0 | 7,705 | D | | | | | | | | | | | | | | |
8/18/20 19:02 | 8/16/20 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 5 | 0 | 7,702 | D | | | | | | | | | | | | | | |
8/5/20 18:47 | 8/3/20 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S.m | -2,178 | 27.23 | 0 | -80 | -1 | 7,699 | I | | | | | | | | | | | | | | |
7/6/20 19:18 | 7/1/20 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S.m | -4,411 | 30.75 | 0 | -143 | -2 | 7,779 | I | | | | | | | | | | | | | | |
6/10/20 16:09 | 6/8/20 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | -318 | 30.01 | 0 | -11 | 0 | 7,922 | I | | | | | | | | | | | | | | |
6/5/20 19:55 | 6/3/20 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S.d | -178 | 30.05 | 0 | -6 | 0 | 7,933 | I | | | | | | | | | | | | | | |
6/3/20 16:06 | 6/1/20 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | -2,335 | 29.19 | 0 | -80 | -1 | 7,939 | I | | | | | | | | | | | | | | |
5/6/20 20:21 | 5/5/20 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | -2,469 | 31.02 | 0 | -80 | -1 | 8,019 | I | | | | | | | | | | | | | | |
5/5/20 16:05 | 5/1/20 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S.m | -2,364 | 29.40 | 0 | -80 | -1 | 8,098 | I | | | | | | | | | | | | | | |
4/9/20 16:05 | 4/7/20 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | -46 | 25.48 | 0 | -2 | 0 | 8,179 | I | | | | | | | | | | | | | | |
4/6/20 21:17 | 4/3/20 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | -8 | 25.09 | 0 | 0 | 0 | 8,181 | I | | | | | | | | | | | | | | |
4/3/20 16:10 | 4/1/20 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S.m | -2,026 | 26.02 | 0 | -78 | -1 | 8,181 | I | | | | | | | | | | | | | | |
3/4/20 17:55 | 3/2/20 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S.m | -3,874 | 32.28 | 0 | -120 | -1 | 8,259 | I | | | | | | | | | | | | | | |
2/7/20 17:40 | 2/5/20 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | -1,077 | 34.87 | 0 | -31 | 0 | 8,378 | I | | | | | | | | | | | | | | |
2/5/20 17:04 | 2/3/20 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | See Rema | S.m | -3,092 | 34.70 | 0 | -89 | -1 | 8,409 | I | | | | | | | | | | | | | | |
1/6/20 21:15 | 1/2/20 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | See Rema | S.m | -3,902 | 32.52 | 0 | -120 | -1 | 8,832 | I | | | | | | | | | | | | | | |
7/8/19 21:32 | 7/3/19 | EIDX | Eidos Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DOT | CEO | P | 26,383 | 29.90 | 0 | 882 | 4 | 24,576 | I | | | | | | | | | | | | | | |
7/3/19 16:12 | 7/1/19 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | See Rema | M.d | 0 | 0.00 | 0 | 8,952 | | 8,552 | M | | | | | | | | | | | | | | |
5/29/19 19:15 | 5/24/19 | EIDX | Eidos Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DOT | CEO | P | 28,623 | 25.93 | 0 | 1,104 | 5 | 23,693 | I | | | | | | | | | | | | | | |
6/22/18 18:56 | 6/22/18 | EIDX | Eidos Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DOT | CEO | P.d | 17,000 | 17.00 | 0 | 1,000 | 5 | 19,615 | I | | | | | | | | | | | | | | |